Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

计划入组 220 人 · 首次发布于 2026 年 6 月 17 日

GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

计划入组 150 人 · 首次发布于 2026 年 8 月 26 日

Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 Diabetes

计划入组 19 人 · 首次发布于 2012 年 4 月 5 日

GLP-1-GIP(MeiraGTx)

GLP-1/GIP/glucagon receptor agonist (obesity)

Retatrutide

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Hengrui and Kailera Present Phase 2 Data for Dual GLP-1/GIP Agonist and Oral GLP-1 Therapies at ADA 2025

Chugai Licenses Roche's CT-388 Dual GLP-1/GIP Receptor Agonist for Japan Market

Neurocrine Biosciences Launches Phase I Trial of GLP-1/GIP/Glucagon Triple Agonist NBIP-1968 for Obesity